Microwave Thermotherapy (CPB 0682, reviewed 2025-10-15)
Summary
Aetna considers microwave thermotherapy medically necessary for clinical stage T1 renal lesions, for medically inoperable non-small cell lung cancer lesions less than 3 cm, and for hepatocellular carcinoma tumors less than or equal to 3 cm. Aetna considers microwave thermotherapy experimental, investigational or unproven for bladder cancer, bone cancer and limb salvage, breast cancer and breast cancer metastasis, cervical ectopy, chronic low back and neck pain, chronic pelvic pain syndrome, chronic prostatitis, cutaneous verrucae, dysmenorrhea, endometrial cancer, keratoconus, nasopharyngeal cancer, osteosarcoma, pancreatic cancer, rheumatoid arthritis and vulvar lichen sclerosus. Microwave thermotherapy enhanced with hybrid magnetic nanoparticles for liver cancer and microwave thermotherapy combined with TIPE2 for colon cancer are also experimental, investigational or unproven.
Get alerts when payers change rules like this one
We check Aetna and other payers every day and email you when a change matches your specialty and state.